Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus (Q35933731)

11 August 2017

1 reference

title

Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus (English)

1 reference

11 August 2017

0 references

1 reference

2

Caroline M Perry

1 reference

11 August 2017

Therese M Chapman

1

1 reference

11 August 2017

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

64

1 reference

11 August 2017

22

1 reference

11 August 2017

2577-2595

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464220-00008

11 August 2017

0 references

cites work

The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin

1 reference

12 December 2020

Secretory expression of human albumin domains in Saccharomyces cerevisiae and their binding of myristic acid and an acylated insulin analogue.

1 reference

12 December 2020

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

1 reference

12 December 2020

Engineering predictability and protraction in a basal insulin analogue: the pharmacology of insulin detemir

1 reference

12 December 2020

A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mell

1 reference

12 December 2020

Variability of insulin absorption and insulin action

1 reference

12 December 2020

At last, a weight neutral insulin?

1 reference

12 December 2020

Implications of the Diabetes Control and Complications Trial

1 reference

12 December 2020

Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic properties of long-acting insulin analogue NN304 in comparison to NPH insulin in humans

1 reference

12 December 2020

Mechanism of protracted metabolic effects of fatty acid acylated insulin, NN304, in dogs: retention of NN304 by albumin

1 reference

12 December 2020

Effect of fatty acids and selected drugs on the albumin binding of a long-acting, acylated insulin analogue

1 reference

12 December 2020

1 reference

12 December 2020

Insulin glargine: an updated review of its use in the management of diabetes mellitus

1 reference

12 December 2020

The physiological basis of insulin treatment--clinical aspects

1 reference

12 December 2020

Insulin Detemir Is Characterized by a Consistent Pharmacokinetic Profile Across Age-Groups in Children, Adolescents, and Adults With Type 1 Diabetes

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs

1 reference

12 December 2020

Insulin delivery using pen devices. Simple-to-use tools may help young and old alike

1 reference

12 December 2020

Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes.

1 reference

12 December 2020

Validation of the CORE Diabetes Model against epidemiological and clinical studies

1 reference

12 December 2020

Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus

1 reference

12 December 2020

Limitations to subcutaneous insulin administration in type 1 diabetes

1 reference

12 December 2020

Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo

1 reference

12 December 2020

Diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

Long-acting insulin analogs.

1 reference

12 December 2020

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen

1 reference

12 December 2020

Insulin detemir: improving the predictability of glycaemic control

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

New insulins in the treatment of diabetes mellitus

1 reference

12 December 2020

Implications of the United kingdom prospective diabetes study

1 reference

12 December 2020

Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304

1 reference

12 December 2020

Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus

1 reference

12 December 2020

Can we reduce hypoglycaemia with insulin detemir?

1 reference

12 December 2020

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

1 reference

12 December 2020

Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine

1 reference

12 December 2020

Crystal structure of a prolonged-acting insulin with albumin-binding properties

1 reference

12 December 2020

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

1 reference

12 December 2020

1 reference

12 December 2020

Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy

1 reference

12 December 2020

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

1 reference

12 December 2020

Structural effects of protein lipidation as revealed by LysB29-myristoyl, des(B30) insulin

1 reference

12 December 2020

The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy for the treatment of type 1 diabetes

1 reference

12 December 2020

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial

1 reference

12 December 2020

10.2165/00003495-200464220-00008

Identifiers

DOI

1 reference

PubMed ID

15516157

Dimensions Publication ID

11 August 2017

0 references

1 reference

PubMed ID

15516157